Connect with us

Technology

Heart Attack Diagnostics Market to Reach $21.1 Billion, Globally, by 2033 at 8.6% CAGR: Allied Market Research

Published

on

The global heart attack diagnostics market is experiencing growth due to several factors such as increase in prevalence of cardiovascular diseases, technological advancement in diagnostic techniques, and growing awareness among both healthcare providers and patients about the importance of early detection and intervention in preventing adverse outcomes from heart attacks.

WILMINGTON, Del., Aug. 20, 2024 /PRNewswire/ — Allied Market Research published a report, titled, “Heart Attack Diagnostics Market by Type (Electrocardiogram, Blood Tests, Angiogram, Computerized Cardiac Tomography and Others), and End User (Hospitals, Diagnostics Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2024-2033″. According to the report, the heart attack diagnostics market was valued at $9.2 billion in 2023, and is estimated to reach $21.1 billion by 2033, growing at a CAGR of 8.6% from 2024 to 2033.

Request Sample of the Report on Heart Attack Diagnostics Market Forecast 2033 – https://www.alliedmarketresearch.com/request-sample/A12689 

Prime determinants of growth

The heart attack diagnostics market is experiencing significant growth driven by several key factors such as advancements in medical imaging technologies have revolutionized the early detection and accurate diagnosis of heart conditions, including heart attacks. For instance, the widespread adoption of advanced imaging modalities such as cardiac MRI and CT angiography allows healthcare professionals to visualize heart anatomy and blood flow with exceptional detail, facilitating prompt diagnosis and treatment decisions. Furthermore, the rising prevalence of lifestyle-related risk factors, such as obesity, sedentary lifestyles, and unhealthy dietary habits, has contributed to an increased incidence of heart attacks globally. This growing burden of cardiovascular diseases underscores the importance of robust diagnostic tools and strategies to effectively manage and prevent heart attacks.

As a result, there is a growing demand for innovative diagnostic solutions capable of identifying individuals at high risk of cardiac events and guiding personalized interventions to mitigate these risks. Moreover, the increasing adoption of telemedicine and remote monitoring solutions has expanded access to cardiac diagnostic services, particularly in underserved rural areas and remote regions. Remote monitoring devices, such as wearable ECG monitors and smartphone-based cardiac apps, enable patients to self-monitor their heart health and transmit real-time data to healthcare providers for timely assessment and intervention, thereby facilitating early detection and management of heart attacks.

Report coverage & details:

Report Coverage

Details

Forecast Period

2024–2033

Base Year

2023

Market Size in 2022

$9.2 Billion

Market Size in 2032

 $21.1 Billion

CAGR

8.60 %

No. of Pages in Report

260

Segments Covered

Type, End User and Region.

Drivers

Advancements in Medical Imaging Technologies

Increase in Prevalence of Cardiovascular Disease

Adoption of Telemedicine and Remote Monitoring Solutions

Opportunities

Technological Innovations and Product Development

Market Expansion in Emerging Economies

Focus on Personalized Medicine

Restraint

High Cost of Advanced Diagnostic Technologies

Have a Question? Connect to our Analyst – https://www.alliedmarketresearch.com/connect-to-analyst/A12689 

Segment Highlights

ECG remains a basic diagnostic tool for assessing cardiac function and detecting abnormalities indicative of a heart attack. Technological advancements, such as portable and wireless ECG devices, have enhanced accessibility and convenience for both patients and healthcare providers, leading to early detection and timely intervention. For instance, the emergence of smartphone-connected ECG monitors, such as the Apple Watch with its ECG app, enables users to perform ECGs conveniently at home, empowering individuals to monitor their heart health proactively.

Blood tests also contribute significantly to the heart attack diagnostics market, serving as valuable tools for assessing cardiac biomarkers indicative of myocardial injury or ischemia. High-sensitivity troponin assays enable rapid and precise detection of cardiac troponin levels, aiding in the early diagnosis and risk stratification of heart attacks. The increasing availability of point-of-care testing solutions further accelerates diagnostic turnaround times, facilitating prompt clinical decision-making and patient management in emergency settings.

Angiography, another essential test type in the heart attack diagnostics market, involves imaging the coronary arteries to identify blockages or narrowing that may lead to a heart attack. Traditional coronary angiography, performed invasively via cardiac catheterization, has been complemented by non-invasive techniques such as computed tomography angiography (CTA), which offers high-resolution imaging of the coronary arteries without the need for invasive procedures. This advancement reduces patient discomfort and procedural risks while providing clinicians with detailed anatomical information for accurate diagnosis and treatment planning.

Additionally, computerized cardiac tomography, including techniques such as coronary calcium scoring and coronary CT angiography, has gained prominence as non-invasive imaging modalities for assessing coronary artery disease and identifying individuals at risk of heart attacks. These imaging techniques offer superior sensitivity and specificity in detecting coronary artery lesions, enabling early intervention and preventive strategies to mitigate the risk of adverse cardiac events.

North America to maintain its dominance by 2033

By region, North America held the largest market share in terms of revenue in 2023 and is expected to dominate the market during the forecast period. This is attributed to its advanced technology infrastructure, strong demand & availability of heart attack diagnostic devices, supportive regulatory environment, and collaborative ecosystem fostering innovation and market growth in the market. However, the Asia-Pacific region is expected to witness the highest growth during the forecast period.

For Purchase Related Queries/Inquiry – https://www.alliedmarketresearch.com/purchase-enquiry/A12689
 
In developing countries such as China and India, the heart attack diagnostics market presents unique opportunities driven by several factors such as high burden of cardiovascular diseases due to a combination of demographic, socio-economic, and lifestyle factors. In addition, the rapid expansion of healthcare infrastructure and increase in focus on improving access to quality healthcare services present significant opportunities for market growth.

Key Players

Bionet Co. Ltd.Toshiba CorporationBio-Rad Laboratories Inc.Life Sign LLC Schiller AGBeckman CoulterGE HealthcareHitachi Medical SystemsF. Hoffmann-La Roche Ltd.Abbott Laboratories

The report provides a detailed analysis of these key players in the global heart attack diagnostics market. These players have adopted different strategies such as new product launches, collaborations, expansion, joint ventures, agreements, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.

Recent Development:

In February 2023, Cardio Diagnostics Holdings launched PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.In April 2021, Roche launched a series of five new intended uses for two key cardiac biomarkers using the Elecsys technology: highly sensitive cardiac troponin T (cTnThs) and N-terminal pro-brain natriuretic peptide test (NT-proBNP). These gold standard biomarkers have proven to be successful in supporting cardiovascular disease management and can help clinicians diagnose heart attacks (cTnT-hs) and better manage heart failure (NT-proBNP).In March 2021, the European Union approved the artificial intelligence-based CaRi-Heart Technology to detect and predict the risk of severe heart attack years before it happens. The CaRi-Heart Technology was developed by the British Heart Foundation and Caristo Diagnostics.

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int’l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com  
Follow Us on: LinkedIn

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/heart-attack-diagnostics-market-to-reach-21-1-billion-globally-by-2033-at-8-6-cagr-allied-market-research-302226324.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Boqii Announces ADS Ratio Change

Published

on

By

SHANGHAI, Jan. 10, 2025 /PRNewswire/ — Boqii Holding Limited (“Boqii” or the “Company”) (NYSE American: BQ) today announced that it will change its ratio of its American Depositary Shares (“ADSs”) to Class A ordinary shares from one (1) ADS representing fifteen (15) Class A ordinary shares to one ADS representing one hundred and fifty (150) Class A ordinary shares (the “ADS Ratio Change”). The ADS Ratio Change is expected to become effective on or about January 21, 2025 (U.S. Eastern Time) (the “ADS Ratio Change Effective Date”).

For Boqii’s ADS holders, the ADS Ratio Change will have the same effect as a 1-for-10 reverse split on the existing ADSs. Each ADS holder on the ADS Ratio Change Effective Date will be required on mandatory basis to surrender to The Bank of New York Mellon, as depositary, (the “Depositary”) for Boqii’s ADS program, every 10 old ADSs held in exchange for one new ADSs. No action is required by holders of uncertificated ADSs to effect the ADS Ratio Change as the change will be effected on the books of the Depositary.  

No fractional new ADSs will be issued in connection with the ADS Ratio Change. Instead, the Depositary will attempt to sell any fractional entitlements to new ADSs and the net cash proceeds from the sale of the fractional ADS entitlements (after deduction of fees, taxes and expenses) will be distributed to the applicable ADS holders by the Depositary. Boqii’s ADSs will continue to be traded on the NYSE American under the ticker symbol “BQ”. As a result of the ADS Ratio Change, the ADS price is expected to increase proportionally, although the Company can give no assurance that the ADS price after the ADS Ratio Change will be equal to or greater than ten (10) times the ADS price before the change.

 About Boqii Holding Limited 

Boqii Holding Limited (NYSE American: BQ) is a leading pet-focused platform in China. It is the leading online destination for pet products and supplies in China with a broad selection of high-quality products including global leading brands, local emerging brands, and its own private label, Yoken, Mocare and D-cat, offered at competitive prices. Boqii’s online sales platforms, including Boqii Mall and our flagship stores on third-party e- commerce platforms, provide customers with convenient access to a wide selection of high-quality pet products and an engaging and personalized shopping experience. Its Boqii Community provides an informative and interactive content platform for users to share their knowledge and love for pets.

Safe Harbor Statement 

This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the Company’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and a number of factors could cause actual results to differ materially from those contained in any forward-looking statement. In some cases, forward-looking statements can be identified by words or phrases such as “may,” “will,” “expect,” “anticipate,” “target,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. The Company may also make written or oral forward-looking statements in its reports filed with, or furnished to, the U.S. Securities and Exchange Commission (“SEC”), in its annual reports to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Further information regarding such risks, uncertainties or factors is included in the Company’s filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any duty to update such information, except as required under applicable law.

For investor inquiries, please contact: 

Boqii Holding Limited
Investor Relations
Tel: +86-21-6882-6051
Email: ir@boqii.com 

View original content:https://www.prnewswire.com/news-releases/boqii-announces-ads-ratio-change-302348055.html

SOURCE Boqii Holding Limited

Continue Reading

Technology

NASA Awards 2025 Innovative Technology Concept Studies

Published

on

By

WASHINGTON, Jan. 10, 2025 /PRNewswire/ — NASA selected 15 visionary ideas for its NIAC (NASA Innovative Advanced Concepts) program which develops concepts to transform future missions for the benefit of all. Chosen from companies and institutions across the United States, the 2025 Phase I awardees represent a wide range of aerospace concepts.

The NIAC program nurtures innovation by funding early-stage technology concept studies for future consideration and potential commercialization. The combined award for the 2025 concepts is a maximum of $2.625M in grants to evaluate technologies that could enable future aerospace missions.

“Our next steps and giant leaps rely on innovation, and the concepts born from NIAC can radically change how we explore deep space, work in low Earth orbit, and protect our home planet” said Clayton Turner, associate administrator for NASA’s Space Technology Mission Directorate in Washington. “From developing small robots that could swim through the oceans of other worlds to growing space habitats from fungi, this program continues to change the possible.”

The newly selected concepts include feasibility studies to explore the Sun’s influence on our solar system, build sustainable lunar habitats from glass, explore Saturn’s icy moon, and more. All NIAC studies are in the early stages of conceptual development and are not considered official NASA missions.

Ryan Weed, Helicity Space LLC in Pasadena, California, proposes a constellation of spacecraft powered by the Helicity Drive, a compact and scalable fusion propulsion system, that could enable rapid, multi-directional exploration of the heliosphere and beyond, providing unprecedented insights on how the Sun interacts with our solar system and interstellar space. Demonstrating the feasibility of fusion propulsion could also benefit deep space exploration including crewed missions to Mars.

Martin Bermudez, Skyeports LLC in Sacramento, California, presents the concept of constructing a large-scale, lunar glass habitat in a low-gravity environment. Nicknamed LUNGS (Lunar Glass Structure), this approach involves melting lunar glass compounds to create a large spherical shell structure. This idea offers a promising solution for establishing self-sustaining, large-scale habitats on the lunar surface.

Justin Yim, University of Illinois in Urbana, proposes a jumping robot appropriately named LEAP (Legged Exploration Across the Plume), as a novel robotic sampling concept to explore Enceladus, a small, icy moon of Saturn that’s covered in geysers, or jets. The LEAP robots could enable collection of pristine, ocean-derived material directly from Enceladus’s jets and measurement of particle properties across multiple jets by traveling from one to another.

“All advancements begin as an idea. The NIAC program allows NASA to invest in unique ideas enabling innovation and supporting the nation’s aerospace economy,” said John Nelson, program executive for NASA’s Innovative Advanced Concepts in Washington.

The NIAC researchers, known as fellows, will investigate the fundamental premise of their concepts, identify potential challenges, and look for opportunities to bring these concepts to life.

In addition to the projects mentioned above, the following selectees received 2025 NIAC Phase I grants:

Michael Hecht, Massachusetts Institute of Technology, Cambridge: EVE (Exploring Venus with Electrolysis)Selim Shahriar, Northwestern University, Evanston, Illinois: SUPREME-QG: Space-borne Ultra-Precise Measurement of the Equivalence Principle Signature of Quantum GravityPhillip Ansell, University of Illinois, Urbana: Hy2PASS (Hydrogen Hybrid Power for Aviation Sustainable Systems)Ryan Benson, ThinkOrbital Inc., Boulder, Colorado: Construction Assembly DestinationGyula Greschik, Tentguild Engineering Co, Boulder, Colorado: The Ribbon: Structure Free Sail for Solar Polar ObservationMarco Quadrelli, NASA’s Jet Propulsion Laboratory in Southern California: PULSAR: Planetary pULSe-tAkeRBen Hockman, NASA’s Jet Propulsion Laboratory in Southern California: TOBIAS: Tethered Observatory for Balloon-based Imaging and Atmospheric SamplingKimberly Weaver, NASA’s Goddard Space Flight Center in Greenbelt, Maryland: Beholding Black Hole Power with the Accretion Explorer InterferometerJohn Mather NASA’s Goddard Space Flight Center in Greenbelt, Maryland: Inflatable Starshade for Earthlike ExoplanetsRobert Hinshaw, NASA’s Ames Research Center in California’s Silicon Valley: MitoMars: Targeted Mitochondria Replacement Therapy to Boost Deep Space EnduranceChristine Gregg, NASA’s Ames Research Center in California’s Silicon Valley: Dynamically Stable Large Space Structures via Architected MetamaterialsSaurabh Vilekar, Precision Combustion, North Haven, Connecticut: Thermo-Photo-Catalysis of Water for Crewed Mars Transit Spacecraft Oxygen Supply

NASA’s Space Technology Mission Directorate funds the NIAC program, as it is responsible for developing the agency’s new cross-cutting technologies and capabilities to achieve its current and future missions.

To learn more about NIAC, visit:

https://www.nasa.gov/niac

View original content to download multimedia:https://www.prnewswire.com/news-releases/nasa-awards-2025-innovative-technology-concept-studies-302348385.html

SOURCE NASA

Continue Reading

Technology

Corn Next Launches CornNext-17: A Groundbreaking Sustainable Solution to Plastic Pollution

Published

on

By

IRVINE, Calif., Jan. 11, 2025 /PRNewswire/ — Corn Next, a leader in sustainable innovation and biodegradable solutions, has officially launched CornNext-17, a game-changing bio-based material designed to combat the global plastic pollution crisis. Accompanying this launch is the release of the CornNext-17 White Paper, a detailed report that highlights the revolutionary features of CornNext-17, its potential to replace traditional plastics, and its critical role in supporting global sustainability initiatives.

Derived from renewable corn starch, CornNext-17 utilizes a patented fermentation-based process to create a fully biodegradable material with superior versatility and performance. Unlike traditional plastics and bio-plastics such as PLA and PHA, CornNext-17 retains its natural polysaccharide structure, enabling rapid decomposition within 30 days in natural environments while maintaining the mechanical properties necessary for diverse applications.

“CornNext-17 represents a significant leap forward in sustainable materials,” said Randy Yongzhong Zhang, Founder and CEO of Corn Next. “We are proud to offer a solution that addresses the urgent need for environmentally friendly alternatives to conventional plastics. The development of CornNext-17 is guided by our vision to revolutionize how materials are used and discarded. As a fully natural biodegradable innovation, it marks not just a breakthrough in material science, but a significant milestone in humanity’s pursuit of a greener, more sustainable future.”

Key Features of CornNext-17

Fully Biodegradable: Decomposes naturally within 30 days, leaving no harmful residues.Versatile: Suitable for a wide range of applications, including packaging, consumer goods, and industrial components.Cost-Effective: Produced through an efficient manufacturing process, offering competitive pricing.High Performance: Exhibits excellent mechanical properties, including strength, flexibility, and heat resistance.Eco-Friendly: Derived from renewable corn starch and produced without harmful chemicals.

Market Potential and Industrial Applications

CornNext-17 has the potential to transform multiple industries by replacing traditional plastics with a sustainable alternative:

Consumer Goods: CornNext-17 is ideal for creating compostable tableware, single-use products, food containers, and eco-friendly packaging solutions that cater to environmentally conscious consumers.Packaging Industry: The material’s strength, flexibility, and resistance to heat and moisture make it a superior choice for biodegradable packaging, including retail, food, and industrial applications.Agriculture: CornNext-17 can be used to manufacture biodegradable mulch films, seedling trays, and irrigation components, reducing waste and enhancing soil health.Medical and Healthcare: With its ability to decompose fully, CornNext-17 is well-suited for disposable medical supplies such as gloves, syringes, and packaging, ensuring environmental safety.Automotive: Lightweight and durable, CornNext-17 can be utilized in creating automotive components such as panels, trim, and interior parts, contributing to vehicle sustainability and fuel efficiency.Electronics: As a biodegradable alternative, CornNext-17 can replace certain plastic components in electronics, helping reduce electronic waste.

The global push for environmentally sustainable materials positions CornNext-17 to capitalize on increasing regulatory support and consumer demand for green products. Its adaptability, cost-effectiveness, and eco-friendly properties provide a competitive edge in addressing the growing plastic pollution crisis.

Why CornNext-17 Matters

Plastic waste remains one of the most pressing environmental challenges, with over 400 million tons of plastic produced annually and only a fraction recycled. CornNext-17’s innovative composition and rapid biodegradability make it a transformative solution for reducing reliance on petrochemical-based plastics and mitigating environmental harm.

Looking for Partnership

Corn Next is committed to advancing CornNext-17’s applications through ongoing research and development, fostering innovation in biodegradable materials. The company seeks strategic collaborations with industry leaders, partners, investors, financial institutions, government agencies, and research organizations to drive the widespread adoption of CornNext-17 and accelerate the global shift toward a more sustainable future.

Download the White Paper

Detailed information on the potential of this revolutionary material can be downloaded from Corn Next’s website at https://www.cornnext.com/CornNext-17 by clicking “Learn More.”

About Corn Next

Corn Next (or Y & J World Inc.) is a pioneering biotech company based in Irvine, California, dedicated to eliminating plastic pollution. We specialize in developing bio-based new materials such as CornNext-17, a patented, 100% natural, biodegradable material derived from renewable corn starch. Unlike traditional plastics, CornNext-17 fully decomposes within 30 days without leaving toxins or requiring costly recycling. After eight years of R&D, we transformed CornNext-17 into a granular form, securing our proprietary technology and expanding its applications. This innovation led to the world’s first corn-based drinking straw, protein spoon, dinner knife, and forks, with future uses in utensils, dental floss, packaging and more. Corn Next is committed to replacing single-use and durable plastics with sustainable, plastic-free alternatives—free from plastics, PHA, PLA, and other bio-plastics. Our mission is to drive a cleaner, greener future. For more information, please visit https://www.cornnext.com/

Contact: David Xu, Email: david.x@cornnext.com

SOURCE Corn Next Inc.

Continue Reading

Trending